ITGAM and breast cancer: In a study of 4T1 mouse breast cancer, the authors found that Gr1+CD11b+ cells are a major source of TGFβ in the TME, and depletion of these cells abrogates the anti-tumor effect of pan-TGFβ inhibition33.